0
ARTICLE |

Drug Prophylaxis for Arterial Thromboembolism—1981 FREE

Stanford Wessler, MD
[+] Author Affiliations

Read in part before The Scientific Sessions, American Heart Association, Miami, Nov 18, 1980.

Reprint requests to The New York University School of Medicine, 550 First Ave, New York, NY 10016.


JAMA. 1981;246(21):2484-2487. doi:10.1001/jama.1981.03320210050027
Text Size: A A A
Published online

Recent multicenter clinical trials using platelet-suppressive agents for the secondary prevention of myocardial infarction have yielded inconclusive results, although some of the data suggest possible benefits. For transient ischemic attacks, after carotid artery surgery has been eliminated as an option, aspirin is the drug of choice for men; for women, and for men in whom aspirin fails, warfarin sodium should be considered. Warfarin is indicated after insertion of cardiac prosthetic disk valves, and if systemic emboli occur, dipyridamole should be added. Patients with atrial fibrillation should be treated prophylactically with coumarin agents, but only if underlying organic heart disease is demonstrable.

(JAMA 1981;246:2484-2487)

REFERENCES

Chandler AB, Eurenuis K, McMillan GC, et al (eds): The Thrombotic Process in Atherogenesis . New York, Plenum Press, 1978;, pp 1-546.
 Proceedings of the Workshop on Platelet-Active Drugs in the Secondary Prevention of Cardiovascular Events . Circulation 1980;; 62( (suppl 5) ):1-135.
Butler S: The Note-books of Samuel Butler . London, AC Fifield, 1912;, p 11.
Hull R, Delmore T, Carter C, et al:  A randomized trial of titrated dose subcutaneous (s.c.) heparin versus warfarin in long term treatment of patients with deep venous thrombosis (VT) , abstracted. Circulation 1980;;62( (suppl 3) ):338.
 A randomized control trial of aspirin in persons recovered from myocardial infarction, Aspirin Myocardial Infarction Study Research Group . JAMA 1980;;243:661-669.
Fields WS, Lemak NA, Frankowski RF, et al:  Controlled trial of aspirin in cerebral ischemia . Stroke 1977;;8:301-316.
 A randomized trial of aspirin and sulfinpyrazone in threatened stroke, The Canadian Cooperative Study Group . N Engl J Med 1978;; 299:53-59.
Millikan CH:  Transient cerebral ischemia: Definition and natural history . Prog Cardiovasc Dis 1980;;22:303-308.
Goldner JC, Whisnant JP, Taylor WF:  Long-term prognosis of transient cerebral ischemic attacks . Stroke 1971;;2:160-167.
Schmidley JW, Caronna JJ:  Transient cerebral ischemia: Pathophysiology . Prog Cardiovasc Dis 1980;;22:325-342.
Mohr JP:  Transient ischemic attacks and the prevention of strokes . N Engl J Med 1978;; 299:93-95.
Sullivan JM, Harken DE, Gorlin R:  Pharmacologic control of thromboembolic complications of cardiac-valve replacement . N Engl J Med 1971;;284:1391-1394.
Tinker JH, Tarham S:  Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: Observations in 180 operations . JAMA 1978;;239:738-739.
Wessler S, Gitel SN:  Thrombosis: The relationship of hemostatic mechanisms to drug therapy . J Neurosurg 1981;;54:1-11.
Wessler S:  Thrombosis and sex hormones: A perplexing liaison . J Lab Clin Med 1980;; 96:757-761.
Hall JG, Pauli RM, Wilson KM:  Maternal and fetal sequelae of anticoagulation during pregnancy . Am J Med 1980;;68:122-140.
Becker CG, Dubin T:  Activation of factor XII by tobacco glycoprotein . J Exp Med 1977;; 146:457-467.
Wessler S:  Atherothrombology , in Chandler AB, Eurenuis K, McMillan GC, et al (eds): The Thrombotic Process in Atherogenesis . New York, Plenum Press, 1978;, pp 409-417.
Steele P, Rainwater J:  Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease . Circulation 1980;; 62:462-468.
Easton JD, Sherman DG:  Progress in cerebrovascular disease: Management of cerebral embolism of cardiac origin . Stroke 1980;; 11:433-442.
Bjerkelund C, Orning OM:  The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation . Am J Cardiol 1969;;23:208-216.
Demakis JG, Shahbudin HR, Sutton GC, et al:  Natural course of peripartum cardiomyopathy . Circulation 1971;;44:1053-1061.
McDonald CD, Burch GE, Walsh JJ:  Prolonged bedrest in treatment of idiopathic cardiomyopathy . Am J Med 1972;;52:41-50.
Wessler S, Kleiger RD, Cornfield J, et al:  Coumarin therapy in acute myocardial infarction: A Hobsen's choice . Arch Intern Med 1974;; 134:774-779.
Chalmers TC, Matta RJ, Smith H Jr, et al:  Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction . N Engl J Med 1977;;297:1091-1096.
Fisher CM:  Reducing risks of cerebral embolism . Geriatrics 1979;;34:59-66.
Cabin HS, Roberts WC:  Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease . Chest 1980;;77:586-590.
Staffurth JS, Gibberd MC, Fui SNT:  Arterial embolism in thyrotoxicosis with atrial fibrillation . Br Med J 1977;;3:688-690.
Fairfax AJ, Lambert CD, Leatham A:  Systemic embolism in chronic sinoatrial disorders . N Engl J Med 1976;;295:190-192.
Darsee JR, Mikolich JR, Nicoloff NB, et al:  Prevalence of mitral valve prolapse in presumably healthy young men . Circulation 1979;;59:619-622.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Chandler AB, Eurenuis K, McMillan GC, et al (eds): The Thrombotic Process in Atherogenesis . New York, Plenum Press, 1978;, pp 1-546.
 Proceedings of the Workshop on Platelet-Active Drugs in the Secondary Prevention of Cardiovascular Events . Circulation 1980;; 62( (suppl 5) ):1-135.
Butler S: The Note-books of Samuel Butler . London, AC Fifield, 1912;, p 11.
Hull R, Delmore T, Carter C, et al:  A randomized trial of titrated dose subcutaneous (s.c.) heparin versus warfarin in long term treatment of patients with deep venous thrombosis (VT) , abstracted. Circulation 1980;;62( (suppl 3) ):338.
 A randomized control trial of aspirin in persons recovered from myocardial infarction, Aspirin Myocardial Infarction Study Research Group . JAMA 1980;;243:661-669.
Fields WS, Lemak NA, Frankowski RF, et al:  Controlled trial of aspirin in cerebral ischemia . Stroke 1977;;8:301-316.
 A randomized trial of aspirin and sulfinpyrazone in threatened stroke, The Canadian Cooperative Study Group . N Engl J Med 1978;; 299:53-59.
Millikan CH:  Transient cerebral ischemia: Definition and natural history . Prog Cardiovasc Dis 1980;;22:303-308.
Goldner JC, Whisnant JP, Taylor WF:  Long-term prognosis of transient cerebral ischemic attacks . Stroke 1971;;2:160-167.
Schmidley JW, Caronna JJ:  Transient cerebral ischemia: Pathophysiology . Prog Cardiovasc Dis 1980;;22:325-342.
Mohr JP:  Transient ischemic attacks and the prevention of strokes . N Engl J Med 1978;; 299:93-95.
Sullivan JM, Harken DE, Gorlin R:  Pharmacologic control of thromboembolic complications of cardiac-valve replacement . N Engl J Med 1971;;284:1391-1394.
Tinker JH, Tarham S:  Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: Observations in 180 operations . JAMA 1978;;239:738-739.
Wessler S, Gitel SN:  Thrombosis: The relationship of hemostatic mechanisms to drug therapy . J Neurosurg 1981;;54:1-11.
Wessler S:  Thrombosis and sex hormones: A perplexing liaison . J Lab Clin Med 1980;; 96:757-761.
Hall JG, Pauli RM, Wilson KM:  Maternal and fetal sequelae of anticoagulation during pregnancy . Am J Med 1980;;68:122-140.
Becker CG, Dubin T:  Activation of factor XII by tobacco glycoprotein . J Exp Med 1977;; 146:457-467.
Wessler S:  Atherothrombology , in Chandler AB, Eurenuis K, McMillan GC, et al (eds): The Thrombotic Process in Atherogenesis . New York, Plenum Press, 1978;, pp 409-417.
Steele P, Rainwater J:  Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease . Circulation 1980;; 62:462-468.
Easton JD, Sherman DG:  Progress in cerebrovascular disease: Management of cerebral embolism of cardiac origin . Stroke 1980;; 11:433-442.
Bjerkelund C, Orning OM:  The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation . Am J Cardiol 1969;;23:208-216.
Demakis JG, Shahbudin HR, Sutton GC, et al:  Natural course of peripartum cardiomyopathy . Circulation 1971;;44:1053-1061.
McDonald CD, Burch GE, Walsh JJ:  Prolonged bedrest in treatment of idiopathic cardiomyopathy . Am J Med 1972;;52:41-50.
Wessler S, Kleiger RD, Cornfield J, et al:  Coumarin therapy in acute myocardial infarction: A Hobsen's choice . Arch Intern Med 1974;; 134:774-779.
Chalmers TC, Matta RJ, Smith H Jr, et al:  Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction . N Engl J Med 1977;;297:1091-1096.
Fisher CM:  Reducing risks of cerebral embolism . Geriatrics 1979;;34:59-66.
Cabin HS, Roberts WC:  Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease . Chest 1980;;77:586-590.
Staffurth JS, Gibberd MC, Fui SNT:  Arterial embolism in thyrotoxicosis with atrial fibrillation . Br Med J 1977;;3:688-690.
Fairfax AJ, Lambert CD, Leatham A:  Systemic embolism in chronic sinoatrial disorders . N Engl J Med 1976;;295:190-192.
Darsee JR, Mikolich JR, Nicoloff NB, et al:  Prevalence of mitral valve prolapse in presumably healthy young men . Circulation 1979;;59:619-622.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.